Banner
Home

OIG Takes Notice as Compound Drug Use Skyrockets Print E-mail
Written by Vitale Health Law   
Tuesday, 04 September 2018 16:54
 
The cost of compounded topical drugs to the country's Medicare program has  skyrocketed over the past several years, and that's gotten the attention of a government watchdog agency. In a recently released report, the U.S. Department of Health and Human Services Office of Inspector General (OIG) found that Medicare Part D spending for these drugs was 24 times higher in 2016 than in 2010.
 

Last Updated on Tuesday, 04 September 2018 16:59
 


Banner
Website design, development, and hosting provided by
Netphiles